Stock TARO TARO PHARMACEUTICAL INDUSTRIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Taro Pharmaceutical Industries Ltd.

Equities

TARO

IL0010827181

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
42.4 USD -0.19% Intraday chart for Taro Pharmaceutical Industries Ltd. +0.36% +1.48%
Jan. 25 Taro Pharmaceutical Industries Fiscal Q3 Net Income, Net Sales Rise; Shares Climb After Hours MT
Jan. 25 Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Taro Pharmaceutical Industries Ltd. Appoints Mr. Oded H. Sarig, Ph. D, to Serve as Director
CI
Taro Pharmaceutical Industries Ltd. Announces Resignation of Dov Pekelman from the Board of Directors
CI
Taro Pharmaceutical Industries Appoints William Coote as Finance, Accounting Chief
MT
Taro Pharmaceutical Industries Ltd. Appoints William J. Coote as Chief Financial Officer
CI
Taro Pharmaceutical Industries Ltd. Announces Appointment of William J. Coote as Vice President and Chief Accounting Officer
CI
Taro Pharmaceutical Industries Ltd. Announces Resignation of Daphne Huang, Chief Financial Officer, Effective August 6, 2021
CI
Taro Pharmaceutical Industries Ltd. Appoints Daphne Huang as Vice President, CFO and Chief Accounting Officer, Effective April 6, 2020
CI
Taro Pharmaceutical Industries Ltd. Accepts Resignation of Its Chief Financial Officer, Mariano Balaguer, Effective January 3, 2020
CI
Taro Pharmaceutical Industries Ltd. Announces Executive Changes
CI
Taro Pharmaceutical Industries Ltd. Appoints Abhay Gandhi as Interim Ceo, Effective January 1, 2017
CI
Taro Pharmaceutical Industries Ltd. Announces Executive Changes
CI
AmerisourceBergen : Drugmakers under fire for possible U.S. price fixing
RE
Taro Pharmaceutical Industries Ltd. Appoints Mariano Balaguer as Vice President, CFO and Chief Accounting Officer
CI
Kal Sundaram to Step Down as CEO of Taro Pharmaceutical Industries Ltd
CI
Taro Pharmaceutical Industries Ltd. Announces Resignation of Michael Kalb as Chief Financial Officer, with Effect from June 29, 2016
CI
BlueMountain Capital Intends to Nominate Candidates to the Board of to Taro Pharmaceutical
CI
Taro Pharmaceutical Industries Ltd. Announces Management Changes
CI
Taro Pharmaceutical Industries Ltd. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TARO Stock
  4. News Taro Pharmaceutical Industries Ltd.
  5. Insiders